Magee Thomson Investment Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-29,710
Closed -$6.87M 107
2016
Q2
$6.87M Sell
29,710
-2,930
-9% -$676K 2.4% 25
2016
Q1
$8.75M Buy
32,640
+5,730
+21% +$1.64M 2.76% 20
2015
Q4
$8.41M Sell
26,910
-16,560
-38% -$4.93M 2.31% 27
2015
Q3
$11.8M Buy
43,470
+7,430
+21% +$2.28M 3.64% 15
2015
Q2
$10.9M Sell
36,040
-36,630
-50% -$10.9M 3.17% 17
2015
Q1
$21.6M Sell
72,670
-2,130
-3% -$607K 5.23% 1
2014
Q4
$19.3M Buy
74,800
+290
+0.4% +$72.5K 4.79% 2
2014
Q3
$18M Buy
74,510
+5,080
+7% +$1.14M 4.43% 3
2014
Q2
$15.5M Sell
69,430
-59,800
-46% -$12.4M 3.78% 8
2014
Q1
$26.6M Sell
129,230
-1,037
-0.8% -$205K 6.04% 1
2013
Q4
$21.9M Sell
130,267
-30,950
-19% -$4.84M 4.84% 2
2013
Q3
$23.2M Sell
161,217
-44,705
-22% -$5.96M 4.67% 2
2013
Q2
$26M Buy
+205,922
New +$23.3M 5.91% 1

Other funds holding AGN

Magee Thomson Investment Partners's AGN Position: Q3 2016 in Review

Magee Thomson Investment Partners sold out of Allergan plc (AGN) in Q3 2016, closing a stake of 29,710 shares — an estimated $6.87M sold.

Magee Thomson Investment Partners first reported a position in AGN in Q2 2013 and held it in 13 quarters. The position peaked at $26.6M in Q1 2014. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

  • Magee Thomson Investment Partners reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
  • Magee Thomson Investment Partners sold 29,710 Allergan plc shares in Q3 2016, an estimated $6.87M.
  • Magee Thomson Investment Partners first reported a position in Allergan plc in Q2 2013 and held it in 13 quarters.
  • Magee Thomson Investment Partners's Allergan plc position peaked at $26.6M in Q1 2014.
  • 1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Magee Thomson Investment Partners's 13F filing for Q3 2016, filed 27 Oct 2016.